Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forward

J Natl Cancer Inst. 2003 Dec 17;95(24):1811-2. doi: 10.1093/jnci/djg133.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Goserelin / therapeutic use*
  • Humans
  • International Cooperation
  • Methotrexate / administration & dosage
  • Multicenter Studies as Topic
  • Ovary / drug effects*
  • Premenopause

Substances

  • Antineoplastic Agents, Hormonal
  • Goserelin
  • Cyclophosphamide
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF regimen